Rare diseases
Investigational molecules
Locations
Back to France263 clinical trials in Avignon, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Capecitabine and Durvalumab for Patients with Removed Biliary Tract Cancer
FranceStudy on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations
FranceStudy of Radiotherapy with Cetuximab and Xevinapant for Patients with Advanced Head and Neck Cancer Unfit for High-Dose Cisplatin
FranceStudy on Stopping Tocilizumab for Patients with Giant Cell Arteritis
FranceComparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer
FranceStudy of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy
FranceStudy on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
FranceStudy on Improving Survival in Acute Myeloid Leukemia for Adults Aged 18-60 Using Idarubicin, Daunorubicin, Cytarabine, and Mycophenolic Acid
FranceStudy on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)
FranceStudy on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment
FranceStudy on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on head and neck cancers, gastric cancer, and pancreatic adenocarcinoma. Studies evaluate novel combination therapies and targeted treatments to improve patient outcomes.
Multiple trials investigating breakthrough treatments for locally advanced and metastatic diseases.
Groundbreaking research in multiple myeloma and lymphoma treatments, exploring novel therapeutic approaches and combination strategies.
Focus on improving treatment outcomes for both newly diagnosed and relapsed patients.
Comprehensive studies of non-small cell lung cancer treatments, investigating immunotherapy combinations and personalized treatment approaches.
Emphasis on developing more effective and tolerable treatment regimens.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
